Synthesis and Absolute Configuration of Substituted Isocoumarins
1201
c ¼ 20 mg cmꢁ 3): ꢃ ¼ 8.30 (dm, J ¼ 7.9Hz, 8-H), 7.76 (ddd, J ¼ 7.8, ꢃ7.5, 1.4 Hz, 6-H), 7.58 (ddd,
J ¼ 7.9, ꢃ7.5, 1.2 Hz, 7-H), 7.53 (br.d, J ¼ 7.8 Hz, 5-H), 7.15 (d, J ¼ 0.5 Hz, 4-H), 2.77 (m, 20-H2), 1.63
(m, 30-H2), 1.02 (t, J ¼ 7.4 Hz, 40-H3) ppm; 13C NMR (CDCl3): ꢃ ¼ 160.8 (s, C-1), 153.8 (s, C-3), 136.0
(s, C-4a), 135.1 (d, C-6), 129.8, 129.5 (2d, C-7, C-8), 127.0 (d, C-5), 120.5 (s, C-8a), 105.2 (d, C-4),
61.7 (s, C-l0), 49.8 (t, C-20), 21.1 (t, C-30), 13.1 (q, C-40) ppm; EIMS (70 eV): m=z (%) ¼ 360 (6, Mþ ),
281=279 (100), 199 (70), 171 (49), 159 (35), 145 (93), 89 (96), 86 (50).
3-(1,2-Dibromobutyl)-1H-2-benzopyran-1-one (10,20-Dibromodihydroartemidin,
4, C13H12Br2O2)
In the bromination reaction of 1, with 1.82 g (9mmol) of 1 and 1.86g of NBS, but without addition of
DBPO and l0h reaction time, the l0,20-bromination product was formed as a side product of the 10-
bromo derivative 2 in the ratio 1:10. The retention time was only a little different from that of 2, but 4
could be crystallized from the earlier (still unpure) fractions of the chromatography (PE:EE¼ 75:25,
1
see above) and recrystallized from PE:EE¼ 80:20. Yield 83 mg (3%); mp 141–143ꢂC; H NMR
(CDCl3, c ¼ 4 mg cmꢁ 3): ꢃ ¼ 8.31 (br.d, J ¼ 8.1 Hz, 8-H), 7.73 (ddd, J ¼ 7.8, ꢃ7.5, 1.2 Hz, 6-H),
7.51 (ddd, J ¼ 8.1, ꢃ7.5, 1.1 Hz, 7-H), 7.45 (br.d, J ¼ 7.8 Hz, 5-H), 6.55 (s, 4-H), 4.84 (d, J ¼
11.3Hz, l0-H), 4.66 (ddd, J ¼ 11.3, 8.0, 2.6Hz, 20-H), 2.43 (ddq, J ¼ 14.6, 7.3, 2.6 Hz, 30-Ha), 2.00
(ddq, J ¼ 14.6, 8.0, 7.3 Hz, 30-Hb), 1.15 (t, J ¼ 7.3 Hz, 40-H3) ppm; 13C NMR (CDCl3): ꢃ ¼ 152.5 (s, C-
3), 135.0 (d, C-6), 129.9 (d, C-8), 129.1 (d, C-7), 126.2 (d, C-5), 121.2 (s, C-8a), 105.8 (d, C-4), 54.8
(d, C-l0), 51.5 (d, C-20), 29.5 (t, C-30), 10.6 (q, C-40) ppm, signals of C-l and C-4a are too weak for
detection; EIMS (70 eV): m=z (%) ¼ 360 (5, Mþ ), 281=279 (25), 201 (49), 200 (54), 189 (100), 159
(43), 131 (31), 89 (46).
(E)-3-(1-Bromo-1-butenyl)-1H-2-benzopyran-1-one ((E)-10-Bromoartemidin,
5, C13H11BrO2)
38mg (0.25 mmol) of DBU were added to a solution of 18mg of 4 in 0.5 cm3 of anhydrous THF under
a flow of N2. After 2.5 h at room temperature the reaction mixture was acidified with 0.5cm3 of 2 M
HCl, saturated with NH4Cl, and extracted with 3 ꢄ 2 cm3 of ether. The combined ether layers were
washed neutral with a solution of saturated aqu. NaCl and dried over MgSO4. After evaporation of the
solvent the remaining yellow oil (15 mg) was purified by repeated preparative TLC (silica gel,
PE:EE¼ 90:10). Yield 5 mg (36%); colourless oil; 1H NMR (CDCl3, c ¼ 2 mgcmꢁ 3): ꢃ ¼ 8.30
(br.d, J ¼ 8.0Hz, 8-H), 7.73 (ddd, J ¼ 7.8, ꢃ7.5, 1.4 Hz, 6-H), 7.53 (ddd, J ¼ 8.0, ꢃ7.5, 1.2 Hz, 7-
H), 7.46 (br.d, J ¼ 7.8 Hz, 5-H), 6.74 (s, 4-H), 6.39 (t, J ¼ 7.8 Hz, 20-H), 2.46 (dq, J ¼ 7.8, 7.5 Hz,
30-H2), 1.11 (t, J ¼ 7.5 Hz, 40-H3) ppm; EIMS (70 eV): m=z (%) ¼ 280=278 (54, Mþ ), 199 (100), 171
(54), 153 (21), 128 (37), 89 (33).
3-(1-Hydroxybutyl)-1H-2-benzopyran-1-one (10-Hydroxydihydroartemidin, 6, C13H14O3)
To a solution of 86mg of 2 in 5 cm3 of acetone 10cm3 of H2O were added under vigorous stirring. The
turbid solution was heated to 90ꢂC for 1 h. Then the reaction mixture was diluted with 10 cm3 of saturated
aqu. NaCl solution and extracted with 5ꢄ5 cm3 of CH2Cl2. The combined organic layers were dried
over MgSO4 and after evaporation practically pure 6 was obtained. Yield 67mg (100%); colorless oil;
1H NMR (CDCl3, c ¼ 20 mg cmꢁ 3): ꢃ ¼ 8.18 (br.d, J ¼ 8.0Hz, 8-H), 7.64 (br.dd, J ¼ 7.8, ꢃ7.5 Hz, 6-H),
7.42 (br.dd, J ¼ 8.0, ꢃ7.5Hz, 7-H), 7.34 (br.d, 1H, J ¼ 7.8 Hz, 5-H), 6.53 (s 4-H), 4.45 (br.t, J ¼ 5.1 Hz,
l0-H), 1.78 (m, 20-Ha þ b), 1.44 (m, 30-H2), 0.92 (t, J ¼ 7.3 Hz, 40-H3), 3.12 (br.s, 10-OH) ppm; 13C NMR
(CDCl3): ꢃ ¼ 162.5 (s, C-1), 158.5 (s, C-3), 136.9 (s, C-4a), 134.8 (d, C-6), 129.4 (d, C-8), 128.0 (d, C-
7), 125.6 (d, C-5), 120.3 (s, C-8a), 102.0 (d, C-4), 70.6 (d, C-l0), 37.1 (t, C-20), 18.5 (t, C-30), 13.7
(q, C-40) ppm; EIMS (70 eV): m=z (%) ¼ 218 (15, Mþ ), 200 (14), 175 (100), 147 (79), 89 (37).